The short version
Just 2 companies supply this market — thin enough that a single exit would be felt immediately.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Diphenhydramine HCl and Ibuprofen
Diphenhydramine HCl and Ibuprofen · DIPHENHYDRAMINE HYDROCHLORIDE 25 mg/1; IBUPROFEN 200 mg/1 · Capsule, Liquid Filled · Oral · Aurohealth LLC
NDC 58602-0717-30 · 160 CAPSULE, LIQUID FILLED in 1 BOTTLE · ANDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Regulatory
- Application
- ANDA210676
- TE code
- —
- Approval date
- Feb 14, 2019
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Diphenhydramine HCl and Ibuprofen (Capsule, Liquid Filled)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Aurobindo Pharma Limited | DIPHENHYDRAMINE HYDROCHLORIDE 25 mg/1; IBUPROFEN 200 mg/1 | Jul 15, 2026 | Sep 3, 2026 |
| Aurohealth LLC | DIPHENHYDRAMINE HYDROCHLORIDE 25 mg/1; IBUPROFEN 200 mg/1 | Jul 15, 2026 | Sep 3, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Diphenhydramine HCl and Ibuprofen — NDC 58602-0717-30," retrieved September 3, 2026, https://drugdashboards.com/drug/58602071730.
Free to cite with attribution — see how the data is put together.